Skip to main content

Day: August 20, 2020

PCSB Financial Corporation Authorizes Stock Repurchase Program

YORKTOWN HEIGHTS, N.Y., Aug. 20, 2020 (GLOBE NEWSWIRE) — PCSB Financial Corporation (the “Company”) (NASDAQ: “PCSB”), parent of PCSB Bank, announced today that it has authorized a program to repurchase up to 844,907 shares, or 5%, of its outstanding common stock.  The timing and amount of any repurchases will depend on various factors, including but not limited to, market conditions, stock price, and alternative uses of capital.  Repurchases may be transacted in the open-market or in negotiated private transactions and may be conducted pursuant to a trading plan adopted in accordance with Securities and Exchange Commission Rule 10b5-1.About PCSB Financial Corporation and PCSB BankPCSB Financial Corporation is the bank holding company for PCSB Bank, a New York-chartered commercial bank.  PCSB Bank has served the banking needs of...

Continue reading

BigCommerce to Announce Second Quarter 2020 Financial Results on September 9, 2020

AUSTIN, Texas, Aug. 20, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading software-as-a-service (SaaS) ecommerce platform that empowers merchants of all sizes to build, innovate and grow their businesses online, today announced that it will report its financial results for the second quarter ended June 30, 2020 after market close on Wednesday, September 9, 2020.The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. CT (5:00 p.m. ET) on Wednesday, September 9, 2020. The conference call can be accessed by dialing (833) 519-1347 from the United States and Canada or (914) 800-3909 internationally with conference ID 5080457. The live webcast of the conference call can be accessed from BigCommerce’s investor relations website at...

Continue reading

R-Three Technologies, Inc. Announces Improved Capital Structure, New Strategic Initiatives

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — R-Three Technologies, Inc. (OTC: RRRT), after several years of inactivity, is pleased to announce that the company is taking measures to deliver increased value for shareholders, via an improved capital structure and the launch of several new, strategic initiatives.As a first initiative, R-Three Technologies, Inc. (OTC: RRRT) has cancelled $564,000 of debt, as per company quarterly filing with OTC. Additionally, R-Three Technologies, Inc. will soon be announcing a new restructuring of its equity.R-Three Technologies, Inc. (OTC: RRRT) has been working diligently on several other new measures that aim to drive shareholder value. These include new mergers and acquisitions strategy and the hiring of a new senior management team to execute these plans.“We’re excited about...

Continue reading

Auris Medical Regains Listing Compliance with NASDAQ Minimum Bid Requirement

Hamilton, Bermuda, August 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has regained compliance with the Nasdaq listing requirements. On August 20, 2020, the Company received a letter from Nasdaq stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten (10) consecutive business days, the Company’s stock had regained compliance with the Minimum Bid Price Requirement for continued listing on Nasdaq, and that the matter is now closed.About Auris MedicalAuris Medical is a biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and...

Continue reading

Kane Biotech to Release Second Quarter 2020 Financial Results on August 27 – Conference Call to Follow

WINNIPEG, Manitoba, Aug. 20, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its second quarter 2020 financial results after market close on Thursday, August 27, 2020.Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.Second Quarter 2020 Results Conference Call Details:The call will also be broadcast live and archived on the Company’s website at www.kanebiotech.com under “News/Events” in the Investors section.About Kane Biotech Inc.Kane Biotech is a biotechnology company engaged in the research,...

Continue reading

Plus Products Reports Second Quarter 2020 Financial Results

SAN MATEO, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis branded products company in the U.S., today released its unaudited financial and operational results for the three and six months ended June 30, 2020, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and on the Canadian Securities Exchange (the “CSE”) website at www.thecse.com.Q2 2020 Financial HighlightsRevenues: Net revenues reached $4.3M in Q2 2020, representing 21% year-over-year growth as compared to Q2 2019 net revenues of $3.6M. The Company continues to see revenue growth driven by its core operations in the California adult-use market, with contributions from new brand launches, the Nevada adult-use market, and its national...

Continue reading

Atrion Corporation Increases Quarterly Cash Dividend by 13%

ALLEN, Texas, Aug. 20, 2020 (GLOBE NEWSWIRE) — Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.55 per share to $1.75 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.75 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2020 to stockholders of record at the close of business on September 15, 2020.Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.Contact:Jeffery StricklandVice President and Chief Financial Officer(972) 390-9800

Continue reading

LPL Financial Closes Lucia Securities Asset Acquisition

Lucia Securities serves more than $1.5 billion of client assets  100 percent of the advisors with Lucia Securities have committed to join LPL  Anticipated transaction multiple continues to be ~6x post-synergy EBITDASAN DIEGO, Aug. 20, 2020 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (collectively with its subsidiaries, “LPL”), today announced that it has closed its acquisition of assets of Lucia Securities, a broker-dealer and registered investment advisor (RIA) based in San Diego. Lucia Securities serves more than $1.5 billion of client assets, which are expected to onboard to LPL’s platform by the end of 2020. All 20 advisors have committed to join LPL and will be doing business with LPL as Lucia Capital Group.“LPL is proud to welcome the Lucia Capital Group team of advisors to our platform,” said Rich...

Continue reading

Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics

The combination of SmartPharm’s Gene Mab™ gene-encoded in vivo expression system and Sorrento’s SARS-CoV-2 neutralizing antibodies may potentially provide longer-acting, single injection protection against COVID-19.Beyond COVID-19, the synergies between Sorrento’s proprietary fully human G-MAB™ Antibody Library and SmartPharm’s Gene-Encoded Therapeutics (GET) Platform are expected to provide a vast product pipeline of novel, long-acting therapeutic proteins for a broad range of diseases, including cancer.SAN DIEGO AND BOSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and SmartPharm Therapeutics, Inc. (“SmartPharm”) announced today the signing of a merger agreement under which Sorrento will acquire SmartPharm, a gene-encoded therapeutics company developing non-viral DNA and RNA gene delivery...

Continue reading

Duke Realty Comments on July and August Rent Collection and Announces Participation in Third Quarter Investor Events

INDIANAPOLIS, Aug. 20, 2020 (GLOBE NEWSWIRE) — Duke Realty Corporation (NYSE: DRE and the “company”), a leading logistics property real estate investment trust (REIT), announced today, the results of rent collection and previously deferred rent repayment activity for the months of July and August.  As of August 20th, the company noted the following results:collection of 97.3 percent of original contractual July rents with combined collections and deferrals totaling 99.9 percent;collection of 99.2 percent of original contractual August rents with combined collections and deferrals totaling 99.6 percent;deferral agreements entered into required tenants to begin repaying deferred rents in July;     – collection of 100 percent of previously deferred rents that were due in July; and     – collection of over 99 percent of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.